SCHEMBL6841543

SCHEMBL6841543

CC(C)(CO)Cc1cccc(C=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 1/20 0.41
GMNN O75496 1/20 0.41
GABBR2 O75899 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
HIF1A Q16665 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13509648 0.85 MAOA (0.41) ALDH1A1MAOAMAOBUNGNPC1
SCHEMBL3645563 0.84 MAOA (0.46) ALDH1A1MAOAMAOBUNGNPC1
SCHEMBL2636655 0.83 MAOA (0.42) ALDH1A1MAOAMAOBUNGNPC1
SCHEMBL30954279 0.80 MAOA (0.41) ALDH1A1MAOAMAOBUNGNPC1
SCHEMBL25949907 0.79 SLC6A2 (0.52) ALDH1A1HIF1AMAOAMAOBUNG
Isophthalic Dicarboxaldehyde SCHEMBL26908502 0.77 UNG (0.46) ALDH1A1MAOAMAOBUNGNPC1
SCHEMBL11646214 0.77 MEN1 (0.47) ALDH1A1MEN1GMNNGABBR2LMNA
SCHEMBL1405364 0.76 MAOA (0.49) ALDH1A1TSHRMAOAMAOBUNG
SCHEMBL29805500 0.76 MAOA (0.49) ALDH1A1TSHRMAOAMAOBUNG
SCHEMBL1653788 0.75 TP53 (0.46) ALDH1A1MEN1GMNNGABBR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040048910-A1 Dialkyl ether di-substituted with formyl, carboxy acid, ester and/or tetrazole, which are on tertiary carbon atoms, e.g., 6-(5-carboxy-5-methylhexyloxy)-2,2-dimethylhexanoic acid; lupus, connective tissue disease, sepsis, joint pain WARNER-LAMBERT COMPANY 2004-03-11 US disclosed
WO-2002030860-A9 KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS INC (US) 2003-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040048910-A1 Dialkyl ether di-substituted with formyl, carboxy acid, ester and/or tetrazole, which are on tertiary carbon atoms, e.g., 6-(5-carboxy-5-methylhexyloxy)-2,2-dimethylhexanoic acid; lupus, connective tissue disease, sepsis, joint pain TLR5, SSB, TLR4 ALDH1A1 3646/4885MEN1 4331/4885GMNN 4739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.